Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-Japan

Publisher Name :
Date: 01-Nov-2016
No. of pages: 40
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-Japan" Report provides an overview of the disease and market size of the CMV for Japan. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.

According to DelveInsight, the total number of Diagnosed Cytomegalovirus (CMV) Infection cases is expected to increase at a CAGR of 0.056% to7,355 cases in 2023. Out of all these high risk categories, Infants have comparatively higher number of CMV prevalent cases than HIV and Transplant patients in Japan. The market size for Cytomegalovirus (CMV) Infection shall reach to USD 68.1 Million by the end of 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs.

- The Report also covers the detailed historical and forecasted epidemiological data covering Japan from 2013-2023.

- It also provides Market size of Cytomegalovirus (CMV) infection for Japan from 2013 and forecasted Market size to 2023.

Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-Japan

Table of Contents

Cytomegalovirus Infections
Disease Overview
Symptoms of cytomegalovirus (CMV) Infection
Etiology
Risk Factors
Pathogenesis of human cytomegalovirus
Pathophysiology of cytomegalovirus infection
Diagnosis
Treatment Algorithm for Cytomegalovirus Infections
Treatment for Congenital CMV Infection
Treatment of Ganciclovir resistant CMV
Treatment Guidelines
Recommendations for Treating Cytomegalovirus Infections
Disease Management
Epidemiology and Patient Population
Japan
Assumptions and Rationale
Total CMV Prevalent, Diagnosed and Treatable Cases
CMV Patients among Transplants
Infant Patients at High Risk of CMV
HIV Patients at High Risk of CMV in Japan
Unmet Medical Needs
Marketed Products
Valcyte (Valganciclovir hydrochloride)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
FOSCAVIR (foscarnet sodium)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
CytoGam (Cytomegalovirus Immune Globulin Intravenous-Human)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
CytoTect CP
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
Valtrex (Valacyclovir hydrochloride)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
SWOT Analysis
Emerging Products Analysis
Emerging Therapies
1. Approved Products
Cytovir CMV: Cell Medica Ltd.
Product Description
Research and Development
Product Development Activities
2. Pipeline Products (Phase III)
CytoTect CP 70: Biotest AG.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Letermovir: Merck & Co.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Brincidofovir: Chimerix Inc.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
ASP0113: Astellas Pharma Global Development, Inc.
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Human Cytomegalovirus Immune Globulin: CSL Behring
Product Description
Advantages & Disadvantages
Research and Development
Product Development Activities
Japan Market Size
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Total CMV Prevalent, Diagnosed and Treatable Cases for Japan (2013-2023)
Table 2: CMV Patients among Transplants in Japan (2013-2023)
Table 3: Infants Patients at High Risk of CMV in Japan (2013-2023)
Table 4: HIV Patients at High Risk of CMV in Japan (2013-2023)
Table 5: Total Market size of Cytomegalovirus (CMV) Infection USD, Million(2013-2023)

List of Figures

Figure 1: Total CMV Prevalent, Diagnosed and Treatable Cases for Japan (2013-2023)
Figure 2: CMV Patients among Transplants in Japan (2013-2023)
Figure 3: Infants Patients at High Risk of CMV in Japan (2013-2023)
Figure 4: HIV Patients at High Risk of CMV in Japan(2013-2023)
Figure 5: Japan market size of Cytomegalovirus (CMV) Infection in USD, Million(2013-2023)
  • Impetigo - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 45
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Pipeline Review, H2 2016, provides an overview of the Impetigo (Infectious Disease) pipeline landscape.Impetigo is a highly contagious skin condition. Impetigo is caused by two bacteria streptococcus pyogenes and staphylococcus aureus. Symptoms include fluid-filled blisters, itchy rash, skin lesions and swollen lymph nodes. Risk factors include skin-to-skin contact, injury to the skin, having diabet......
  • Q Fever - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 41
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Q Fever - Pipeline Review, H2 2016, provides an overview of the Q Fever (Infectious Disease) pipeline landscape.Q fever, also called query fever, is a bacterial infection caused by the bacteria Coxiella burnetii. Common symptoms of Q fever include high fever, cough, headache, diarrhea, nausea, abdominal pain, jaundice and muscle pain. Risk factors include occupations. Treatment includes antibiotics.......
  • Global Niclosamide Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Niclosamide Revenue, means the sales value of Niclosamide This report studies Niclosamide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Shanxi Hanjiang Pharmaceutical - Anhui Topsun Pharmaceutical - Zhengqing Pharmaceutical Group......
  • Global Meningococcal Infections Vaccine Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Meningococcal Infections Vaccine Revenue, means the sales value of Meningococcal Infections Vaccine This report studies Meningococcal Infections Vaccine in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Sanofi-Pasteur - Beijing Tiantan Biologi......
  • United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Market Report 2016
    Published: 29-Nov-2016        Price: US 3800 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Revenue, means the sales value of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections This report studies sales (consumption) of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Pfizer - Merck - Astra......
  • Global Drugs for Clostridium Difficile Infections Market Research Report 2016
    Published: 28-Nov-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Drugs for Clostridium Difficile Infections Revenue, means the sales value of Drugs for Clostridium Difficile Infections This report studies Drugs for Clostridium Difficile Infections in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Absynth......
  • United States Ganciclovir Market Report 2016
    Published: 28-Nov-2016        Price: US 3800 Onwards        Pages: 99
    Notes: Sales, means the sales volume of Ganciclovir Revenue, means the sales value of Ganciclovir This report studies sales (consumption) of Ganciclovir in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Roche - Bausch & Lomb - Fresenius Kabi - Luitpold - Huatai Pharmaceutical - Wuhan Hualong Bio-pharmaceutical - Luoxin - HUBEI KEYI ......
  • Europe Voriconazole Market Report 2016
    Published: 25-Nov-2016        Price: US 3900 Onwards        Pages: 119
    Notes: Sales, means the sales volume of Voriconazole Revenue, means the sales value of Voriconazole This report studies sales (consumption) of Voriconazole in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Teva - GeneTech Pharm - Novartis - Mylan - ......
  • Escherichia coli Infections - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 165
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections - Pipeline Review, H2 2016, provides an overview of the Escherichia coli Infections (Infectious Disease) pipeline landscape.Escherichia coli (E. coli) bacteria normally live in the intestines of healthy people and animals. Escherichia coli infections are caused by coming into contact with the feces, or stool, of humans or animals or drink water or eat food that has been contaminated......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs